Stock market technical analysis forecast | Nasdaq trend research for trading investing | 401k
trading penny stock breakout day investing
Skip Navigation Links
    Home
    •   About US
    Market Activity
    World Indices
    Market Watch
    Customer Service
    Learning Center
    Economic Event
    Login


Join Now




Advertise 2 ۩  Daily market forecast

Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research

MSFT Microsoft Co
SectorSoftware
RecommendationsBuy
Buy Near21.31
Stop Loss20.91
Posted Date6/5/2009 1:32:46 AM
First resistance22.53
Second resistance23.50
Third resistance26.67
First Support20.91
Second Support19.54
Comments
6/4/2009 12:27:56 PM0) Technical Stock research Yesterday Microsoft (MSFT) given a breakout of reverse head and shoulder pattern beside that ADX also indicating up word move for Microsoft (MSFT), rate of change (ROC) got upward momentum with increasing relative price index (RSI). Stock investing with chart pattern Head and solder is a best chaise and as per technical view Microsoft (MSFT) in a short term up trend
1) You can use Microsoft for day trading also.

As per head and shoulder theory for Microsoft our up side target is $26.67
2) So built position with target $26.67 and consider base line as a stop loss ($20.91)
MSFT       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
Dow Jones Falls While Nasdaq Recovers Some Losses; These Dow Stocks Trade Near Buy Zones
(Fri, 26 Feb 2021 21:22:19 +0000)
The Dow Jones Industrial Average traded lower in today's stock market while the Nasdaq lifted higher into the last hour of trading.
SolarWinds’s Security Practices Questioned by Lawmakers
(Fri, 26 Feb 2021 19:20:32 +0000)
(Bloomberg) -- SolarWinds Corp.’s security practices in the years leading up to a major cyber-attack by suspected Russian hackers, who leveraged the company’s software to infiltrate government agencies and private-sector companies, were questioned by lawmakers in Washington.At a Friday hearing on the hack by two House committees, Representative Bennie Thompson, a Democrat from Mississippi and chairman of the Homeland Security Committee, asked SolarWinds representatives about reports of lax security at the company.Kevin Thompson, who served as chief executive officer at the time of the breach, defended SolarWinds, saying it had beefed security in recent years and spent more than most technology companies of similar size.“I believe that we have, over the history of time, taken security seriously -- security of our internal systems, and the secure development of our products,” said Thompson, the former SolarWinds CEO.The cyber-attack was revealed in December after FireEye Inc. discovered it while investigating a breach of its own. The hackers implanted malicious code into SolarWinds’s popular Orion software, and as many as 18,000 customers received it while updating the software. Far fewer were actually targeted for secondary attacks -- about 100 companies and nine U.S. agencies, according to the White House.A persistent question has been how the hackers originally breached SolarWinds. At the hearing, SolarWinds CEO Sudhakar Ramakrishna said the company was still investigating but had narrowed it to three possible methods. The hackers may have used a technique called “password spraying,” where the attackers “spray” passwords at a large volume of usernames. A second possibility was that the hackers stole credentials, he said, while the third was a breach of a third-party application used by SolarWinds.Among the alleged security lapses at SolarWinds that were raised at the hearing was the use of the password “solarwinds123.” A cybersecurity researcher said he notified SolarWinds in 2019 that the password --- to one of its servers -- had leaked online.In addition, lawmakers asked the SolarWinds representatives about a former security adviser who had recommended ways to improve cybersecurity and had stated that “the survival of the company depends on an internal commitment to security.”The hearing was the second time this week that lawmakers heard from technology executives about the cyber-attack. Executives from cybersecurity companies and SolarWinds appeared before the Senate Intelligence Committee on Feb. 23 -- at a hearing in which lawmakers criticized Amazon Web Services for failing to appear before the committee despite an invitation. AWS wasn’t invited to Friday’s hearing, according to a committee aide.Representative Clay Higgins, a Republican from Louisiana, asked about reports the hackers used AWS servers to launch some of the attacks.Brad Smith, the president of Microsoft Corp. and a witness at Friday’s hearing, responded by explaining the need for transparency about cyber-attacks, drawing a contrast between his company and Amazon. “I am here today. I am answering all your questions. Microsoft has published 32 blogs since this came to light. Amazon has yet to publish its first.”An Amazon.com Inc. representative said the company wasn’t affected by “the SolarWinds issue” and didn’t use their software. The cyber-attack “demonstrated the security strengths of the cloud and the importance of modernizing legacy IT systems,” the representative said.Bipartisan leaders of the Senate Intelligence Committee and technology executives who testified at the hearings called for a federal data breach notification law that would require companies to notify the federal government of cyber-attacks. Thompson, the chairman of the Homeland Security Committee, said at Friday’s hearing that he would support such a measure.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Dow Slips As Dems Move To Pass Stimulus Bill; Pelosi Says This Is 'Necessary'; Apple Rebounds
(Fri, 26 Feb 2021 18:42:48 +0000)
The Dow Jones slipped amid a broad rally as Democrats got set to pass a Covid stimulus bill. Nancy Pelosi backed a controversial measure. Apple stock rose.
Dow Jones Dips, Nasdaq Rallies As Tech Stocks Rebound; House To Vote On Stimulus Bill
(Fri, 26 Feb 2021 18:10:01 +0000)
Key market indexes were mixed midday Friday, as the Nasdaq rebounded and the Dow Jones Industrial Average pared a 400-point intraday loss.
Allscripts Healthcare Solutions Inc (MDRX) Q4 2020 Earnings Call Transcript
(Fri, 26 Feb 2021 17:02:02 +0000)
MDRX earnings call for the period ending December 31, 2020.
ARRS ARRIS Group Inc Com
SectorTechnology : Communications Equipment
RecommendationsBuy
Buy Near7.32
Stop Loss6.62
Posted Date1/1/2009 12:00:00 AM
First resistance8.77
Second resistance9.62
Third resistance9.75
First Support7.32
Second Support7.19
Comments
1/1/2009 9:03:06 PM0) ARRIS Group Inc Com (ARRS), yesterday announced that its Advanced Advertising manager solution has successfully interconnected with systems of several leading Advanced Advertising Decision Service and Campaign manager providers at its labs in Beaverton and Stock given a breakout with high volume
1) Again given a buy signal with rising moving average
2) Stockhastic, rate of change (ROC) and ADX also given a buy signal As per technical analysis, Stock analysis and fundamental research ARRIS Group Inc Com (ARRS) Stock looks good candidate for breakout Stock investing as well as you can add in portfolio investment
3) Recently Stock given a breakout with rising moving average and also Stockhastic and Rate of change (ROC) given a buy signal
4) ARRIS Group Inc Com (ARRS) Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
5) Due to Stock market and economic condition keep tight stop loss on all position
6) You can buy this Stock near $7.32
10/16/2005 12:00:00 AM0) ARRIS Group Inc Com (ARRS), yesterday announced that its Advanced Advertising manager solution has successfully interconnected with systems of several leading Advanced Advertising Decision Service and Campaign manager providers at its labs in Beaverton and Stock given a breakout with high volume
1) Again given a buy signal with rising moving average
2) Stockhastic, rate of change (ROC) and ADX also given a buy signal As per technical analysis, Stock analysis and fundamental research ARRIS Group Inc Com (ARRS) Stock looks good candidate for breakout Stock investing as well as you can add in portfolio investment
3) Recently Stock given a breakout with rising moving average and also Stockhastic and Rate of change (ROC) given a buy signal
4) ARRIS Group Inc Com (ARRS) Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
5) Due to Stock market and economic condition keep tight stop loss on all position
6) You can buy this Stock near $7.32
0) Sell sort at 12 with 12.47 stop loss
ARRS       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
AHL Aspen Insurance Holdings Limit
SectorFinancial : Insurance
RecommendationsBuy
Buy Near22.93
Stop Loss22.15
Posted Date1/1/2009 12:00:00 AM
First resistance24.34
Second resistance27.50
Third resistance28.00
First Support22.93
Second Support22.56
Comments
1/1/2009 9:04:46 PM0) Aspen Insurance Holdings Limit (AHL) recently announced that its subsidiary, Aspen Insurance UK Limit, authorized by the Regulation Authority to operate as a branch insurer to underwrite general insurance business in Australia and also announced that A.M
1) Best has affirmed the AAA financial strength ratings of Aspen Bermuda subsidiary, Aspen Insurance Limit and its UK subsidiary, Aspen Insurance UK Limit
2) Again given a buy signal with rising moving average
3) Stockhastic, rate of change (ROC) and ADX also given a buy signal As per technical analysis, Stock analysis and fundamental research this Stock looks good candidate for breakout Stock investing as well as you can add in portfolio investment
4) Aspen Insurance Holdings Limit (AHL) Stock given a breakout with high volume and rising moving average and also Stockhastic & Rate of change ROC) given a buy signal
5) Aspen Insurance Holdings Limit (AHL) Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
6) Due to Stock market and economic condition keep tight stop loss on all position
7) You can buy this Stock near $22.93
AHL        Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
Aspen Declares Dividends on Preference Shares
(Tue, 26 May 2020 20:15:00 +0000)
Aspen Insurance Holdings Limited ("Aspen") (NYSE:AHL) announced today that the Board of Directors has declared the following dividends on its Preference Shares:
Angostura Hosts Interactive Live Series on Instagram to Support International Bartender Community
(Thu, 09 Apr 2020 19:48:00 +0000)
This week the House of Angostura® launched a new live & interactive social media campaign through Instagram®, titled HouseLockDown series, which aims to build and share moral support to the international bar community, those working in hospitality as well as sharing some creative ideas to budding at-home Bartenders.
Aspen Announces Filing of Annual Report on Form 20-F
(Mon, 06 Apr 2020 21:08:00 +0000)
Aspen Insurance Holdings Limited ("Aspen") (NYSE: AHL) has today filed its annual report on Form 20-F for the year ended December 31, 2019 with the U.S. Securities and Exchange Commission ("SEC").
Aspen Appoints Kevin Chidwick as Group Chief Financial Officer
(Mon, 16 Mar 2020 22:10:00 +0000)
Aspen Insurance Holdings Limited ("Aspen") (NYSE: AHL) announced today that Kevin Chidwick has been appointed Group Chief Financial Officer, effective May 1, 2020.
Aspen Reports Results for the Twelve Months Ended December 31, 2019
(Mon, 16 Mar 2020 22:02:00 +0000)
Aspen Insurance Holdings Limited ("Aspen") (NYSE: AHL) reported results today for the twelve months ended December 31, 2019.
CBST CUBIST PHARMACEUTICALS INC COM
SectorBiotechnology & Drugs
RecommendationsBuy
Buy Near23.54
Stop Loss17.82
Posted Date11/2/2008 12:00:00 AM
First resistance25.55
Second resistance26.77
Third resistance 
First Support23.34
Second Support17.82
Comments
11/2/2008 9:05:00 PM0) Biotechnology company Cubist Pharmaceuticals Inc.com (CBST) Stock given a breakout on 10/31/08 with good volume again many technical indicators also have given a buy signal, with rising moving average
1) Stockhastic and ADX also given a buy signal
2) Cubist Pharmaceuticals Inc.com (CBST) announced on 10/16/08 its third-quarter profit jumped 40 percent and Revenue increased 41 percent
3) Cubist Pharmaceuticals Inc.com (CBST) is a drug discovery company
4) As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. Cubist Pharmaceuticals Inc.com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
5) Due to Stock market and economic condition keep tight stop loss on all position
6) You can buy this Stock near $23.54
CBST       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
PETS PETMED EXPRESS INC COM
SectorRetail (Drugs)
RecommendationsBuy
Buy Near16.00
Stop Loss14.20
Posted Date11/2/2008 12:00:00 AM
First resistance17.72
Second resistance19.50
Third resistance 
First Support15.97
Second Support14.20
Comments
11/2/2008 9:06:46 PM0) PetMed Express Inc.com (PETS) Stock has given a buy signal, with rising moving average
1) Stockhastic and ADX also given a buy signal
2) PetMed Express Inc.com (PETS) announced on 10/20/08 its fiscal second-quarter profit climbed 29 percent PetMed Express Inc.com (PETS) is a pet-medication delivery company
3) As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. PetMed Express Inc.com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
4) Due to Stock market and economic condition keep tight stop loss on all position
5) You can buy this Stock near $16.00
PETS       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
ROCE Insights For PetMed Express
(Tue, 09 Feb 2021 14:15:05 +0000)
PetMed Express (NASDAQ:PETS) posted Q3 earnings of $9.29 million, an increase from Q2 of 11.25%. Sales dropped to $65.90 million, a 12.65% decrease between quarters. In Q2, PetMed Express earned $10.47 million, and total sales reached $75.44 million. What Is ROCE? Changes in earnings and sales indicate shifts in PetMed Express's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, PetMed Express posted an ROCE of 0.07%. It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future. View more earnings on PETS Return on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders. In PetMed Express's case, the positive ROCE ratio will be something investors pay attention to before making long-term financial decisions. Q3 Earnings Insight PetMed Express reported Q3 earnings per share at $0.38/share, which did not meet analyst predictions of $0.38/share. See more from BenzingaClick here for options trades from Benzinga12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
PetMed Express, Inc. (NASDAQ:PETS) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
(Fri, 29 Jan 2021 06:55:15 +0000)
Shareholders will be ecstatic, with their stake up 26% over the past week following PetMed Express, Inc. 's...
Why Express, Revlon, and PetMed Express Were Soaring Today
(Wed, 27 Jan 2021 21:20:00 +0000)
Shares of Express (NYSE: EXPR), Revlon (NYSE: REV), and PetMed Express (NASDAQ: PETS) were jumping again as a massive short squeeze on consumer stocks continued into its third day. The squeeze instigated by a group of traders on Gamestop has now spread to other heavily shorted stocks, including AMC Entertainment Holdings and Bed Bath & Beyond, in addition to the group of stocks above. As of 12:13 p.m. EST, Express was the big winner of the bunch, up a whopping 202%, while Revlon had gained 26.2% and PetMed Express was up 20.7%.
Looking Into PetMed Express's Return On Capital Employed
(Wed, 27 Jan 2021 15:13:07 +0000)
Looking at Q3, PetMed Express (NASDAQ:PETS) earned $9.29 million, a 11.25% increase from the preceding quarter. PetMed Express's sales decreased to $65.90 million, a 12.65% change since Q2. In Q2, PetMed Express earned $10.47 million, and total sales reached $75.44 million. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q3, PetMed Express posted an ROCE of 0.07%. Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future. View more earnings on PETS Return on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders. For PetMed Express, the return on capital employed ratio shows the number of assets can actually help the company achieve higher returns, an important note investors will take into account when gauging the payoff from long-term financing strategies. Q3 Earnings Recap PetMed Express reported Q3 earnings per share at $0.38/share, which did not meet analyst predictions of $0.38/share. See more from BenzingaClick here for options trades from BenzingaStocks That Hit 52-Week Highs On Wednesday12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
3 Stocks to Buy With Dividends Yielding More Than 5%
(Wed, 27 Jan 2021 12:32:00 +0000)
Energy stocks currently offer some of the highest dividend yields. Canadian midstream stock Enbridge (NYSE: ENB) is trading at an attractive dividend yield of 6.8%, a yield higher than what the stock has historically offered. Energy stocks' elevated yields, as seen in the graph above, likely reflect the market's concerns relating to the role of oil and gas as energy sources in the long term.
WSBC WESBANCO INC COM
SectorFinancial
RecommendationsBuy
Buy Near27.18
Stop Loss25.46
Posted Date11/2/2008 12:00:00 AM
First resistance28.90
Second resistance30.00
Third resistance31.45
First Support25.46
Second Support22.56
Comments
11/2/2008 9:07:49 PM0) WesBanco, Inc
1) com (WSBC) Stock has given a buy signal, with rising moving average
2) Stockhastic and ADX also given a buy signal
3) WesBanco, Inc
4) com (WSBC) announced on 10/21/08 its net income increased 17.9% during the third quarter of 2008 WesBanco, Inc
5) com (WSBC) is a multi-state bank holding company
6) As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. WesBanco, Inc
7) com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
8) Due to Stock market and economic condition keep tight stop loss on all position
9) You can buy this Stock near $27.18
WSBC       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
WesBanco Announces March Investor Conference Schedule
(Fri, 26 Feb 2021 14:15:00 +0000)
WesBanco, Inc. (Nasdaq:WSBC), a diversified, multi-state bank holding company announced today that Todd F. Clossin, President and Chief Executive Officer, and Robert H. Young, Senior Executive Vice President and Chief Financial Officer, are scheduled to participate in the following virtual investor conferences.
WesBanco Again Ranked by Forbes as One of the Best Banks in America
(Fri, 05 Feb 2021 14:30:00 +0000)
WesBanco, Inc. (Nasdaq: WSBC), a diversified, multi-state bank holding company, announces that its affiliate, WesBanco Bank, has again been named to Forbes magazine's list of the Best Banks in America. The 2021 ranking is WesBanco's eleventh year making the list since its inception during 2010, and second year in a row in the top 15 – coming in as the 12th best bank.
WesBanco CEO and CFO to Participate in the KBW Virtual Winter Financial Services Symposium
(Thu, 04 Feb 2021 21:15:00 +0000)
WesBanco, Inc. (Nasdaq:WSBC), a diversified, multi-state bank holding company announced today that Todd F. Clossin, President and Chief Executive Officer, and Robert H. Young, Senior Executive Vice President and Chief Financial Officer, are scheduled to participate in the KBW Virtual Winter Financial Services Symposium on Thursday, February 11 and Friday, February 12, 2021.
Wesbanco Inc (WSBC) Q4 2020 Earnings Call Transcript
(Wed, 27 Jan 2021 20:30:40 +0000)
WSBC earnings call for the period ending December 31, 2020.
WesBanco, Inc. to Host Earnings Call
(Wed, 27 Jan 2021 13:15:00 +0000)
NEW YORK, NY / ACCESSWIRE / January 27, 2021 / WesBanco, Inc. (NASDAQ:WEY) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on January 27, 2021 at 10:00 AM Eastern Time.
AMED AMEDISYS INC COM
SectorHealthcare
RecommendationsBuy
Buy Near55.13
Stop Loss46.55
Posted Date11/2/2008 12:00:00 AM
First resistance65.08
Second resistance67.29
Third resistance 
First Support55.03
Second Support46.55
Comments
11/2/2008 9:08:49 PM0) Amedisys Inc
1) com (AMED) Stock has given a buy signal, with rising moving average
2) Stockhastic and ADX also given a buy signal
3) Amedisys Inc
4) com (AMED) announced on 10/28/08 its profit grew 16 percent in the third quarter, and revenue jumped 78 percent
5) The company reported stronger admissions growth, and it was operating 150 more health agencies than a year earlier and also raised its full-year estimates, predicting greater profit and revenue Amedisys Inc
6) com (AMED) is a Home nursing company
7) As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. Amedisys Inc
8) com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
9) Due to Stock market and economic condition keep tight stop loss on all position
10) You can buy this Stock near $55.13
AMED       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
AMEDISYS Inc (AMED) Q4 2020 Earnings Call Transcript
(Fri, 26 Feb 2021 00:31:17 +0000)
AMED earnings call for the period ending December 31, 2020.
P/E Ratio Insights for Amedisys
(Thu, 25 Feb 2021 14:54:47 +0000)
Looking into the current session, Amedisys Inc. (NASDAQ:AMED) is trading at $275.15, after a 2.29% decrease. Over the past month, the stock decreased by 4.64%, but over the past year, it actually went up by 58.04%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. Assuming that all other factors are held constant, this could present itself as an opportunity for shareholders trying to capitalize on the higher share price. The stock is currently under from its 52 week high by 15.37%. The P/E ratio measures the current share price to the company's earnings per share. It is used by long-term investors to analyze the company's current performance against its past earnings, historical data and aggregate market data for the industry or the indices, such as S&P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also shows that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. View more earnings on AMED Most often, an industry will prevail in a particular phase of a business cycle, than other industries. Compared to the aggregate P/E ratio of 33.59 in the Health Care Providers & Services industry, Amedisys Inc. has a higher P/E ratio of 56.43. Shareholders might be inclined to think that Amedisys Inc. might perform better than its industry group. It's also possible that the stock is overvalued. There are many limitations to price to earnings ratio. It is sometimes difficult to determine the nature of the earnings makeup of a company. Shareholders might not get what they're looking for, from trailing earnings. See more from BenzingaClick here for options trades from BenzingaAmedisys: Q4 Earnings InsightsPreview: Amedisys's Earnings© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Amedisys, Inc. to Host Earnings Call
(Thu, 25 Feb 2021 14:30:00 +0000)
NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Amedisys, Inc. (NASDAQ:AMED) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021 at 11:00 AM Eastern Time.
Amedisys: Q4 Earnings Insights
(Wed, 24 Feb 2021 22:32:55 +0000)
Shares of Amedisys (NASDAQ:AMED) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 58.51% over the past year to $1.49, which beat the estimate of $1.47. Revenue of $550,705,000 higher by 9.99% year over year, which missed the estimate of $553,370,000. Looking Ahead The upcoming fiscal year's EPS expected to be between $6.25 and $6.47. View more earnings on AMED The upcoming fiscal year's revenue expected to be between $2,275,000,000 and $2,315,000,000. Price Action 52-week high: $325.12 52-week low: $132.95 Price action over last quarter: Up 10.55% Company Overview Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patient's homes throughout the United States. The Hospice segment operates many centers designed to provide comfort and support for terminally ill patients. The Personal Care Segment provides individuals with assistance in the daily living activities. A majority of the company's revenue is derived from the Home Health segment. Additionally, the Hospice segment accounts for a substantial amount of revenue, while the Personal Care segment makes up for the small remaining revenue. See more from BenzingaClick here for options trades from BenzingaPreview: Amedisys's Earnings© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Amedisys Announces Two Executive Promotions
(Wed, 24 Feb 2021 21:05:00 +0000)
Christopher Gerard named President and Chief Operating Officer and Scott Ginn named Executive Vice President and Chief Financial Officer BATON ROUGE, La., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, announces the promotions of Christopher Gerard, to President and Chief Operating Officer, and Scott Ginn, to Executive Vice President and Chief Financial Officer, effective immediately. Paul Kusserow continues his role as Chairman of the Board and Chief Executive Officer. “I am thrilled to announce the appointment by the Board of Directors of Chris Gerard to President and Chief Operating Officer, and Scott Ginn to Executive Vice President and Chief Financial Officer,” stated Chairman and CEO Paul Kusserow. “I have had the privilege of working with Scott since 2014 and Chris since 2017, and the performance of the Company under their leadership has been nothing short of tremendous. Both Chris and Scott bring incredible experience and expertise to our team, and have been key to setting the strategic direction and executing on that strategy to deliver superlative results. Both of these promotions are richly deserved and fully earned as a result of exemplary leadership and achievements. As they take on their new positions, I am confident that both will continue to lead Amedisys–with the support of our management team—to even greater levels of success.” During Gerard’s tenure as Chief Operating Officer, Amedisys has realized clinical and operational success and growth in all three business lines. Under his leadership, Amedisys has: grown its footprint to include 514 care centers which span 39 states and the District of Columbia; become the leader in Home Health quality achieving a Quality of Patient Care Star score of 4.33 stars with 95% of all care centers at 4 stars or above; prospered even with the implementation of the Patient-Driven Groupings Model, the largest payment reform from the Centers for Medicare and Medicaid Services (CMS) in 20 years; and become the third largest hospice provider in the United States. In his leadership roles at Amedisys, most recently as Chief Financial Officer, Ginn has been responsible for all accounting operations, mergers and acquisitions, innovations, cost control systems and financial reporting. He has played a pivotal role in leading financial operations and building strong relationships with our analysts, lenders and shareholders and in growing Amedisys’ revenue from $500 million to over $2 billion. “Amedisys’ vision to become the solution for those who want to age in place has never been more important than it is in today’s reality,” stated Chris Gerard, President and Chief Operating Officer. “I am excited and honored to help lead Amedisys with continued excellence. It’s gratifying to be a part of such an exceptional organization of wonderful caregivers who are committed to the highest quality of patient care.” “It has been a privilege to be a part of Amedisys for the past 14 years,” stated Scott Ginn, Executive Vice President and Chief Financial Officer. “It is rewarding to be a member of a team that helped our Company execute in all areas of our strategy. I’m excited about our opportunities in the future to continue to grow Amedisys which will allow us to provide our excellent clinical care to even more patients across the country.” About Amedisys: Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering patients to manage a chronic disease; or hospice care at the end of life. More than 2,900 hospitals and 78,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 21,000 employees, in 514 care centers in 39 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 418,000 patients and clients in need every year. For more information about the Company, please visit: www.amedisys.com. Contact: Amedisys, Inc.Amedisys, Inc.Investor RelationsMedia Relations855.259.2046225.299.3720IR@amedisys.comKendra.kimmons@amedisys.com


we recommends technically up trend Stocks for portfolio, Breakout stock, Penny Stocks and ETF on the base of technical analysis, news and global events analysis considering that you can plan your Stock Market Day Trading, Swing Trading, Stock trading, stock investing, portfolio, investment strategy.

Next Page >>   

 

























Home for ۩ Day Trading | Breakout Stock trading system | Penny Stock Investing | Market Research

Contact Us | Affiliate | Disclaimer | Feedback | Help | Site Map | RSS  RSS
All Rights Reserved © 2000-2006 Flyingstock.com
Technically up Trend Stocks for Portfolio | Swing Trading with support | resistance | stock research

This Service is solely an information service provided by the automated software tool & is for entertainment purposes only. It should be understood that there is no guarantee that past performance of our stock trading system or day trading Strategy or Penny stock picks will be indicative of future results.